Skip to main content
Premium Trial:

Request an Annual Quote

IDT Signs qPCR Probe Licensing Deal with EliTech

NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.

In a statement, Roman Terrill, general counsel and GMP business unit leader for IDT, said, "MGB Eclipse Probes complement our existing GMP qPCR product portfolio and provide our customers with more choice for probe selection." He noted that many of the firm's customers have already developed qPCR-based diagnostic tests using MGB Eclipse Probes labeled for research use only and that today's deal allows IDT to offer GMP-manufactured probes for laboratory developed tests and other diagnostics products.

MGB Eclipse Probes are comprised of oligonucleotides coupled to fluorescent dyes, Elcipse Dark Quenchers, and minor groove binders. The probes are licensed to Coralville, Iowa-based IDT for use solely in human in vitro diagnostic end-use applications, IDT said.

EliTech, based in Puteaux, France, manufactures and develops in vitro diagnostic equipment and reagents. IDT manufactures custom, synthetic DNA and RNA oligonucleotides for use in biotechnology, clinical diagnostics, and pharmaceutical development.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.